Merck & Co., Inc., known as MSD outside of the United States and Canada, is a global leader in healthcare, offering innovative medicines, vaccines, biologic therapies, and animal health products. It operates with a commitment to improving health and well-being around the world.
The company was founded by George Merck in 1891 and is headquartered in Rahway, New Jersey, United States.
Main Product(s):
Merck's products range widely, including therapies for oncology, neurodegenerative diseases, infectious diseases, diabetes, cardiovascular diseases, and more, as well as a broad portfolio of vaccines for childhood and adult diseases.
Short History of Merck & Co., Inc:
1891 – Merck & Co. was founded by George Merck in New Jersey.
1917 – Merck & Co. was established as a separate American company.
1953 – Merck & Co. merged with Philadelphia-based Sharp & Dohme, Inc.
1993 – Entered into a joint venture with AstraZeneca called Astra Merck.
2009 – Merck merged with Schering-Plough.
2023 – Continues to be a leading company in healthcare and pharmaceuticals.
Key Executives:
Name
Title
Pay
Exercised
Year Born
Mr. Robert M. Davis J.D.
Chairman, President & CEO
6.08M
6.77M
1967
Ms. Caroline Litchfield
Executive VP & CFO
2.8M
N/A
1969
Ms. Jennifer L. Zachary
Executive VP & General Counsel
2.73M
3.46M
1978
Dr. Dean Y. Li M.D., Ph.D.
Executive VP & President of Merck Research Laboratories
3.44M
N/A
1962
Mr. Chirfi Guindo
Senior VP & Chief Marketing Officer for Merck Human Health
1.54M
N/A
1966
Mr. David Michael Williams
Executive VP and Chief Information & Digital Officer
N/A
N/A
1969
Mr. Peter Dannenbaum
Vice President of Investor Relations
N/A
N/A
N/A
Lisa LeCointe-Cephas
Senior VP and Chief Ethics & Compliance Officer
N/A
N/A
1982
Ms. Cristal N. Downing
Executive VP and Chief Communications & Public Affairs Officer